Table 1.
Clinical characteristics of Stage IV cancer patients who received in-hospital CPR.
| Overall patients (n = 3,446) | Survived to discharge (n = 592) | Died during hospitalization (n = 2854) | STD | |
|---|---|---|---|---|
| Age (mean ± SD) | 64.1 ± 14.4 | 65.0 ± 14.2 | 64.0 ± 14.5 | 0.074 |
| Male | 2545 (73.9) | 442 (74.7) | 2103 (73.7) | 0.016 |
| Socioeconomic status | ||||
| Low income | 150 (4.4) | 19 (3.2) | 131 (4.6) | 0.071 |
| ≤Q1 | 1243 (36.1) | 208 (35.1) | 1035 (36.3) | 0.024 |
| Q1–Q3 | 1332 (38.7) | 244 (41.2) | 1088 (38.1) | 0.063 |
| >Q3 | 721 (20.9) | 121 (20.4) | 600 (21.0) | 0.014 |
| Cancer type | ||||
| Oral Cavity | 325 (9.4) | 75 (12.7) | 250 (8.8) | 0.127 |
| Oropharynx | 177 (5.1) | 39 (6.6) | 138 (4.8) | 0.076 |
| Hypopharynx | 174 (5.1) | 38 (6.4) | 136 (4.8) | 0.072 |
| Esophagus | 163 (4.7) | 26 (4.4) | 137 (4.8) | 0.020 |
| Stomach | 194 (5.6) | 16 (2.7) | 178 (6.2) | 0.172 |
| Colon | 238 (6.9) | 43 (7.3) | 195 (6.8) | 0.017 |
| Rectum | 135 (3.9) | 27 (4.6) | 108 (3.8) | 0.039 |
| Liver | 237 (6.9) | 30 (5.1) | 207 (7.3) | 0.091 |
| Lung | 1102 (32.0) | 171 (28.9) | 931 (32.6) | 0.081 |
| Breast | 83 (2.4) | 16 (2.7) | 67 (2.4) | 0.023 |
| Cervix | 38 (1.1) | 8 (1.4) | 30 (1.1) | 0.028 |
| Prostate | 170 (4.9) | 35 (5.9) | 135 (4.7) | 0.053 |
| Bladder | 49 (1.4) | 7 (1.2) | 42 (1.5) | 0.025 |
| Other | 361 (10.5) | 61 (16.9) | 300 (10.5) | 0.007 |
| CPR year | ||||
| 2009 | 579 (16.8) | 108 (18.2) | 471 (16.5) | 0.046 |
| 2010 | 656 (19.0) | 117 (19.7) | 539 (18.9) | 0.022 |
| 2011 | 655 (19.0) | 116 (19.6) | 539 (18.9) | 0.018 |
| 2012 | 609 (17.7) | 108 (18.2) | 501 (17.6) | 0.018 |
| 2013 | 568 (16.5) | 88 (14.9) | 480 (16.8) | 0.054 |
| 2014 | 379 (11.0) | 55 (9.3) | 324 (11.4) | 0.068 |
| CCI (mean ± SD) | 3.90 ± 2.20 | 4.12 ± 2.31 | 3.85 ± 2.17 | 0.119 |
| Anti-cancer therapy | 2553 (74.1) | 430 (72.6) | 2123 (74.4) | 0.040 |
| Chemotherapy | 2175 (63.1) | 361 (70.0) | 1814 (63.6) | 0.053 |
| Radiotherapy | 1595 (46.3) | 285 (48.1) | 1310 (45.9) | 0.045 |
| TKI | 316 (9.2) | 52 (8.8) | 264 (9.3) | 0.016 |
| Interval between cancer diagnosis and index admission (mean ± SD) | 317.1 ± 388.3 | 327.1 ± 395.8 | 315.0 ± 386.8 | 0.031 |
| Primary disease for admission | ||||
| Cancer-related | 2325 (67.5) | 380 (64.2) | 1945 (68.2) | 0.082 |
| Cardiovascular | 117 (3.4) | 22 (3.7) | 95 (3.3) | 0.021 |
| Gastrointestinal | 77 (2.2) | 8 (1.4) | 69 (2.4) | 0.078 |
| Neurologic | 20 (0.6) | 7 (1.2) | 13 (0.5) | 0.081 |
| Renal | 19 (0.6) | 4 (0.7) | 15 (0.5) | 0.019 |
| Respiratory | 476 (13.8) | 100 (16.9) | 376 (13.2) | 0.104 |
| Sepsis | 23 (0.7) | 3 (0.5) | 20 (0.7) | 0.025 |
| Trauma | 17 (0.5) | 5 (0.8) | 12 (0.4) | 0.054 |
| Other | 372 (10.8) | 63 (10.6) | 309 (10.8) | 0.006 |
| Receiving cardioversion | 613 (17.8) | 114 (19.3) | 499 (17.5) | 0.046 |
| CPR duration (minutes) | 23 ± 17 | 17 ± 13 | 24 ± 18 | 0.409 |
Note: CCI, charlson comorbidity index; CPR, cardiopulmonary resuscitation; SD, standard deviation; STD, standardized difference; TKI, tyrosine kinase inhibitor.
Data are number (%) unless otherwise mentioned.
Percentages in the three columns are for the column and not the row.